Abstract
Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis are pressing health concerns in modern societies for which effective therapies are still lacking. Recent high-throughput genomic technologies have enabled genome-scale, multidimensional investigations to facilitate a better understanding of the underlying mechanisms and the identification of novel targets. Here we review the molecular insights gained through such studies, and compare the similarities and differences between neurodegenerative diseases revealed by systems genomics and gene network modelling approaches. We focus specifically on the shared mechanisms at multiple molecular scales ranging from genetic factors to gene expression to network-level features of gene regulation, and whenever possible also point out mechanisms that distinguish one disease from another. Our review sets the stage for similar genomewide inspection in the future on shared/distinct features of neurodegenerative diseases at the levels of cellular, proteomic or epigenomic signatures, and how these features may interact to determine the progression and treatment response of different diseases afflicting the same individual.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Al-Chalabi A, Fang F., Hanby M. F., Leigh P. N., Shaw C. E et al. 2010 An estimate of amyotrophic lateral sclerosis heritability using twin data. J. Neurol. Neurosurg. Psychiatry 81, 1324–1326.
Bertram L. and Tanzi R. E. 2005 The genetic epidemiology of neurodegenerative disease. J. Clin. Invest. 115, 1449–1457.
Brown B. C, A. G. E. N. Type 2 Diabetes Consortium, Ye C. J., Price A. L. and Zaitlen N. 2016 Transethnic genetic-correlation estimates from summary statistics. Am. J. Hum. Genet. 99, 76–88.
Cooper-Knock J., Kirby J., Ferraiuolo L., Heath P. R., Rattray M. and Shaw P. J. 2012 Gene expression profiling in human neurodegenerative disease. Nat. Rev. Neurol. 8, 518–530.
Fortune M. D., Guo H, Burren O, Schofield E, Walker N. M. and Ban M. 2015 Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls. Nat. Genet. 47, 839–846.
Gatz M., Reynolds C. A, Fratiglioni L., Johansson B, Mortimer J. A, Berg S. et al. 2006 Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry 63, 168–174.
Grünblatt E., Zander N., Bartl J., Jie L., Monoranu C. M., Arzberger T. et al. 2007 Comparison analysis of gene expression patterns between sporadic Alzheimer’s and Parkinson’s disease. J. Alzheimers Dis. 12, 291–311.
Hamza T. H. and Payami H. 2010 The heritability of risk and age at onset of Parkinson’s disease after accounting for known genetic risk factors. J. Hum. Genet. 55, 241–243.
Ho R., Sances S., Gowing G., Amoroso M. W., O’Rourke J. G., Anais S. et al. 2016 ALS disrupts spinal motor neuron maturation and aging pathways within gene co-expression networks. Nat. Neurosci. 19, 1256–1267.
Hodges A., Strand A. D., Aragaki A. K., Kuhn A., Sengstag T., Hughes G et al. 2006 Regional and cellular gene expression changes in human Huntington’s disease brain. Hum. Mol. Genet. 15, 965–977.
Hosp F., Vossfeldt H., Heinig M., Vasiljevic D., Arumughan A., Wyler E. et al. 2015 Quantitative interaction proteomics of neurodegenerative disease proteins. Cell Rep. 11, 1134–1146.
Kotni M. K., Zhao M. and Wei D. Q. 2016 Gene expression profiles and protein-protein interaction networks in amyotrophic lateral sclerosis patients with C9orf72 mutation. Orphanet. J. Rare Dis. 11, 148.
Klein R. J., Zeiss C., Chew E. Y., Tsai J. Y., Sackler R. S., Haynes C. et al. 2005 Complement factor H polymorphism in age-related macular degeneration. Science 308, 385–389.
Kramer N. J., Haney M. S., Morgens D. W., Jovicic A., Couthouis J., Li A. et al. 2018 CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity. Nat. Genet. 50, 603–612.
Lambert J. C, Ibrahim-Verbaas C. A., Harold D., Naj A. C., Sims R., Bellenguez C. et al. 2013 Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet. 45, 1452–1458.
Li M. D., Burns T. C., Morgan A. A. and Khatri P. 2014 Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases. Acta Neuropathol. Commun. 2, 93.
Li P., Nie Y. and Yu J. 2015 An effective method to identify shared pathways and common factors among neurodegenerative diseases. PLoS One 10, e0143045.
Liu Y., Koyutürk M., Maxwell S., Zhao Z. and Chance M. R. 2012 Integrative analysis of common neurodegenerative diseases using gene association, interaction networks and mRNA expression data. AMIA Jt. Summits Transl. Sci. Proc. 2012, 62–71.
Liu Y. I., Wise P. H. and Butte A. J. 2009 The “etiome”, identification and clustering of human disease etiological factors. BMC Bioinformatics 10, suppl 2, S14.
López González I., Garcia-Esparcia P., Llorens F. and Ferrer I. 2016 Genetic and transcriptomic profiles of inflammation in neurodegenerative diseases, Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies. Int. J. Mol. Sci. 17, 206.
Lynch M. A., Hardiman O., Elamin M., Kirby J. and Rowland L. P. 2016 Common themes in the pathogenesis of neurodegeneration. In Neurodegenerative disorders, a clinical guide (ed. O. Hardiman, C. P. Doherty, M. Elamin and P. Bede), pp. 1–12. Springer International Publishing, Cham.
Narayanan M., Huynh J. L., Wang K., Yang X., Yoo S., McElwee J. et al. 2014 Common dysregulation network in the human prefrontal cortex underlies two neurodegenerative diseases. Mol. Syst. Biol. 10, 743.
Parikshak N. N., Gandal M. J. and Geschwind D. H. 2015 Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. Nat. Rev. Genet. 16, 441–458.
Pasinelli P. and Brown R. H. 2006 Molecular biology of amyotrophic lateral sclerosis, insights from genetics. Nat. Rev. Neurosci. 7, 710–723.
Pickrell J. K., Berisa T, Liu J. Z., Ségurel L., Tung J. Y., Hinds D. A. et al. 2016 Detection and interpretation of shared genetic influences on 42 human traits. Nat. Genet. 48, 709–717.
Portela A. and Esteller M. 2010 Epigenetic modifications and human disease. Nat. Biotechnol. 28, 1057–1068.
Ramanan V. K. and Saykin A. J. 2013 Pathways to neurodegeneration, mechanistic insights from GWAS in Alzheimer’s disease, Parkinson’s disease, and related disorders. Am. J. Neurodegener. Dis. 2, 145–175.
Sanchez-Mut J. V., Heyn H., Vidal E., Moran S., Sayols S., Delgado-Morales R. et al. 2016 Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns. Transl. Psychiatry 6, e718.
Santiago J. A., Bottero V. and Potashkin J. A. 2017 Dissecting the molecular mechanisms of neurodegenerative diseases through network biology. Front. Aging Neurosci. 9, 166.
Saris C. G., Horvath S., van Vught P. W., van Es M. A., Blauw H. M., Fuller T. F. et al. 2009 Weighted gene co-expression network analysis of the peripheral blood from amyotrophic lateral sclerosis patients. BMC Genomics 10, 405.
Shu L., Chan K. H. K., Zhang G., Huan T., Kurt Z., Zhao Y. et al. 2017 Shared genetic regulatory networks for cardiovascular disease and type 2 diabetes in multiple populations of diverse ethnicities in the United States. PLoS Genet. 13, e1007040.
Twine N. A., Janitz K., Wilkins M. R. and Janitz M. 2011 Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer’s disease. PLoS One 6, e16266.
Urdinguio R. G., Sanchez-Mut J. V. and Esteller M. 2009 Epigenetic mechanisms in neurological diseases, genes, syndromes, and therapies. Lancet Neurol. 8, 1056–1072.
van Blitterswijk M., DeJesus-Hernandez M. and Rademakers R. 2012 How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia, can we learn from other noncoding repeat expansion disorders? Curr. Opin. Neurol. 25, 689–700.
Van Cauwenberghe C., Van Broeckhoven C. and Sleegers K. 2016 The genetic landscape of Alzheimer disease, clinical implications and perspectives. Genet. Med. 18, 421–430.
Welter D., MacArthur J., Morales J., Burdett T., Hall P., Junkins H. et al. 2014 The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 42, D1001–1006.
Acknowledgements
This work was partially supported by the Intramural Programme of NIAID (National Institute of Allergy and Infectious Diseases) at the National Institutes of Health (NIH) to MN, NIH grants DK104363 and NS103088 to XY, and UCLA Hyde Fellowship to DA.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Arneson, D., Zhang, Y., Yang, X. et al. Shared mechanisms among neurodegenerative diseases: from genetic factors to gene networks. J Genet 97, 795–806 (2018). https://doi.org/10.1007/s12041-018-0963-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12041-018-0963-3